Viewing Study NCT03542461


Ignite Creation Date: 2025-12-24 @ 1:05 PM
Ignite Modification Date: 2026-01-03 @ 6:47 PM
Study NCT ID: NCT03542461
Status: UNKNOWN
Last Update Posted: 2022-10-03
First Post: 2018-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Early Switch Maintenance vs Delayed Second-line Nivolumab in Advanced Stage Squamous Non-small Cell Lung Cancer (NSCLC) Patients (EDEN Trial)
Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module